Sinopharm COVID-19 vaccine

Sinopharm COVID-19 vaccine received WHO’s approval for emergency use. This Chinese-made vaccine is the first non-western jab to get the WHO’s backing and will possibly be used of COVAX programme, which provides vaccine support low and middle-income countries. It is an inactivated coronavirus vaccine. Its efficacy is estimated to be 79 per cent for all symptomatic and hospitalised. However, there are doubts about its efficacy in people aging above 59 years.

Comments

Leave a Reply